<DOC>
	<DOCNO>NCT02268669</DOCNO>
	<brief_summary>The conceptual hypothesis study primary angioplasty superior combine strategy immediate thrombolysis follow routine angioplasty patient ST-segment elevation acute myocardial infarction ( STEMI ) , even inherent delay transfer patient .</brief_summary>
	<brief_title>Comparison Primary PCI vs. Post-thrombolysis PCI Reperfusion Strategies STEMI</brief_title>
	<detailed_description>This randomize , multicenter , open-label clinical trial compare two strategy reperfusion STEMI . Patients randomly allocate : primary angioplasty post-thrombolysis angioplasty . A clinical follow-up perform 12 month . In trial , 1444 patient STEMI randomize primary angioplasty immediate stent implantation least infarct related artery ( IRA ) bivalirudin protection , combine strategy immediate thrombolysis tenecteplase ( TNK ) enoxaparin follow cardiac catheterization adequate revascularization indicate next morning randomization . Primary endpoint : To compare clinical efficacy ( incidence composite endpoint form death , reinfarction , new revascularization , rehospitalization severe hemorrhage within 12 month ) primary angioplasty versus thrombolytic treatment follow percutaneous coronary intervention ( PCI ) next day patient STEMI . Secondary endpoint : - Components composite endpoint individually analyse 12 month ( death , reinfarction , new revascularization , rehospitalization severe hemorrhage ) . - Cardiovascular mortality different component ( pre-specified case report form , CRF ) 12 month . - Incidence composite endpoint form death , reinfarction , new revascularization , rehospitalization and/or hemorrhage 30 day . - Incidence major bleed event hospitalization 30 day . - To compare clinical efficacy treatment accord time presentation symptom onset ( 0 3 hour , &gt; 3-6 hour , &gt; 6-12 hour ) , patientÂ´s age ( &gt; &lt; 75 year ) , infarction localization ( anterior inferior ) , gender ( male female ) , presence diabetes mellitus characteristic recruit center ( without 24-hour catheterization facility ) . - Incidence composite endpoint form death , reinfarction , new revascularization , rehospitalization and/or hemorrhage 3 year . - Components composite endpoint individually analyse 3 year ( death , reinfarction , new revascularization , rehospitalization severe hemorrhage ) . - Analysis stent thrombosis accord Academic Research Consortium ( ARC ) definition ( http : //www.fda.gov/ohrms/dockets/ac/06/transcripts/2006-4253t2.rtf . ) within 30 day , 12 month 3 year . - To compare combination death , reinfarction , revascularization , rehospitalization and/or major hemorrhage patient treat primary angioplasty versus assign postrombolysis angioplasty underwent catheterization follow day within 30 day , 12 month 3 year . - To compare every indivicual component combine endpoint ( death , reinfarction , revascularization , rehospitalization major hemorrhage ) patient treat primary angioplasty versus assign postrombolysis angioplasty underwent catheterization follow day within 30 day , 12 month 3 year . - To compare cost-effectiveness relationship ( cost maintain patient alive without adverse cardiovascular event within first year post-infarction ) strategy .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Age &gt; 18 year Chest discomfort &gt; 30 minute response nitroglycerin Time onset symptom randomization 0 12 hour ST segment elevation &gt; 1 mm two contiguos precordial lead nondiagnostic ECG ( leave bundle branch block pacemarker rhythm ) classic symptom . Killip class equal le 3 Written inform consent Cardiogenic shock define systolic blood pressure &lt; 90 mm Hg without response fluid administration &lt; 100 mm Hg patient supportive treatment bradycardia Suspicion evidence mechanical complication STEMI Noncardiac disease likely jeopardize compliance followup schedule study ( life expectancy &lt; 1 year ) woman childbearing potential unless negative pregnant test Major contraindication thrombolytic therapy Participation trial Known multivessel disease identify unsuitable revascularization Known peripheral vascular disease complicate cardiac catheterization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>primary angioplasty</keyword>
	<keyword>post-thrombolysis angioplasty</keyword>
	<keyword>ST elevation acute myocardial infarction</keyword>
</DOC>